Bo Norrving, MD1; Jon Barrick, MBA;2 Antoni Davalos, MD;3 Martin Dichgans, MD;4 Charlotte Cordonnier, MD;5 Jill Farrington, MD;6 Alla Guekht, MD;7 Kursad Kutluk, MD;8 Robert Mikulik, MD;9 Joanna Wardlaw, MD;10 Edo Richard, MD;11 Darius Nabavi, MD;12 Carlos Molina, MD;13 Philip Bath, FMedSci;14 Katharina Stibrant Sunnerhagen MD;15 Anthony Rudd, FRCP;16 Avril Drummond, PhD;17 Anna Planas, MD; 18 Valeria Caso, MD,19 on behalf of the Action Plan for Stroke in Europe working group*
*See Appendix 1 for the full list of the working group members.
1Department of Clinical Sciences Lund, Neurology, Skåne University Hospital, Lund University, Lund, Sweden; 2Stroke Alliance for Europe, London, UK; 3Department of Neurosciences,
Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Spain; 4Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians University, Munich, German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, and Munich Cluster of Systems Neurology (SyNergy), Munich, Germany; 5Department of Neurology, CHU Lille, Lille, France; 6World Health Organisation, Copenhagen, Denmark; 7Clinical Center for Neuropsychiatry, Russian National Research Medical University, Moscow, Russia; 8Department of Neurology, Stroke Unit, University of Dokuz Eylul, Izmir, Turkey; 9International Clinical Research Center and Neurology Department, St Anne's University Hospital Brno and Masaryk University Brno, Czech Republic; 10Centre for Clinical Neurosciences, Edinburgh Imaging and UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK; 11Department of Neurology, Radboud University Medical Center, Nijmegen, and department of Neurology, Academic Medical Centre, Amsterdam, the Netherlands; 12Department of Neurology with stroke unit, Vivantes Hospital Neukölln, Berlin, Germany; 13Stroke Unit, Department of Neurology, Hospital Vall d´Hebron Barcelona, Spain; 14Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; ), 15Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden; 16Guy's and St Thomas' NHS Foundation Trust, Stroke NHS England and Royal College of Physicians, London, UK; 17School of Health Sciences, University of Nottingham, UK; 18Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; 19Stroke Unit, Department of Medicine and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
European Stroke Action Plan (ESAP)
Correspondence to Bo Norrving, MD, Department of Clinical Sciences, Neurology, Department of Neurology, Skåne University Hospital, S-221 86 Lund, Sweden, Tel +46 70 538 11 43, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
*See Appendix 1 for the full list of the working group members.
Website by Studio Mzlaki